Goals of introducing clinical cancer registries at risk by the end of 2017
The German Bundestag decided to set up clinical cancer registries back in 2013. Now the National Association of Statutory Health Insurance Funds takes a sobering assessment of the implementation so far. At a press conference on Thursday, the chairwoman of the GKV umbrella association, Dr. Doris Pfeiffer, how far the development of clinical cancer registries in Germany has progressed and what difficulties exist.
Clinical cancer registries should actually be established in all federal states by the end of 2017 according to the decision of the Bundestag. With their help, oncological quality reporting is to be ensured and early cancer detection and care to be improved. A report commissioned by the National Association of Statutory Health Insurance Funds has now shown that only ten federal states have made the necessary anchoring of the corresponding requirements in the respective state law. Only three federal states will deliver the intended output in the report as of 2018 according to the target achievement forecast: Hamburg, Mecklenburg-West Pomerania and the Saarland.
Bad target achievement forecast for some federal states
Cancer is the second leading cause of death in Germany and 500,000 new cases occur every year - and the trend is rising, reports Doris Pfeiffer at the press conference. Every second cancer patient dies from his illness. The introduction of the cancer registry is intended to enable significant improvements in early detection and treatment, but implementation is slow, not least because the law gives the countries a lot of leeway. The target achievement forecast for the federal states of Berlin, Brandenburg, Lower Saxony, North Rhine-Westphalia and Schleswig-Holstein by 2018 is extremely critical in the report that Prognos AG prepared on behalf of the GKV umbrella association. Cancer registries in these countries are unlikely to be completed on time.
Pushing the development of cancer registries forward
According to Doris Pfeiffer, the remaining time must be used urgently to speed up the development of the cancer registry. The corresponding laws must be passed in all federal states by the end of 2016 and the different structural decisions of the federal states must not jeopardize the achievement of objectives, according to Pfeiffer. The National Association of Statutory Health Insurance Funds will support the health insurance companies in checking the registers and has the task of developing nationwide assessment standards for compliance with the eligibility criteria. (fp)